VYOME HOLDINGS, INC. Proceeds from Issuance of Debt
VYOME HOLDINGS, INC. (HIND) reported Proceeds from Issuance of Debt of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-08-12
- VYOME HOLDINGS, INC. proceeds from issuance of debt for the quarter ending 2025-12-31 was $0.00.
- VYOME HOLDINGS, INC. proceeds from issuance of debt for the quarter ending 2025-09-30 was $0.00.
- VYOME HOLDINGS, INC. proceeds from issuance of debt for the quarter ending 2020-12-31 was $0.00.
- VYOME HOLDINGS, INC. proceeds from issuance of debt for the quarter ending 2020-09-30 was $0.00.
- VYOME HOLDINGS, INC. proceeds from issuance of debt for fiscal 2025 was $600.00K.
- VYOME HOLDINGS, INC. proceeds from issuance of debt for fiscal 2020 was $955.00K.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $600.00K 10-K · filed 2026-03-18 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $600.00K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $600.00K 10-Q · filed 2026-08-12 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $0.00 derived: sum of 2 quarters · filed 2022-04-08 | $955.00K 10-K · filed 2022-04-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $955.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $955.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |